{
    "Trade/Device Name(s)": [
        "SYNCHRON\u00ae Systems HDL Cholesterol (HDLX) Reagent"
    ],
    "Submitter Information": "Beckman Coulter, Inc.",
    "510(k) Number": "K100010",
    "Predicate Device Reference 510(k) Number(s)": [
        "K040692"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "LBS"
    ],
    "Summary Letter Date": "May 10, 2010",
    "Summary Letter Received Date": "May 11, 2010",
    "Submission Date": "December 18, 2009",
    "Regulation Number(s)": [
        "21CFR862.1475"
    ],
    "Regulation Name(s)": [
        "Lipoprotein Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "HDL Cholesterol"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Heparin tube",
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "SYNCHRON LX\u00ae System",
        "UniCel\u00ae DxC 800 System"
    ],
    "Method(s)/Technology(ies)": [
        "Chromogenic colorimetric assay",
        "Timed-endpoint absorbance measurement"
    ],
    "Methodologies": [
        "Colorimetric detection",
        "Enzyme assay (cholesterol esterase and oxidase)"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for SYNCHRON Systems HDL Cholesterol (HDLX) Reagent for quantitative determination of HDL cholesterol in serum or plasma using SYNCHRON LX and UniCel DxC 800 systems.",
    "Indications for Use Summary": "Intended for quantitative determination of HDL cholesterol in high density lipoprotein fraction of human serum or plasma to aid in diagnosis and treatment of lipid disorders, atherosclerosis, liver, and renal diseases, and cardiovascular risk assessment.",
    "fda_folder": "Clinical Chemistry"
}